(Reuters) -Vaxart said on Wednesday it received an order to stop work on screening and enrollment for its COVID-19 mid-stage ...

Director Jay Bhattacharya claims the federal government recently canceled millions of dollars’ worth of mRNA research ...

RNA drugs might be able to protect against a huge range of viruses by turning on key parts of our innate defences against ...

Fox News senior medical analyst Dr. Marc Siegel reveals what he learned from his interview with National Institutes of Health ...

Doctors and scientists who spoke to HuffPost are worried for a multitude of reasons and want you to know that this will ...

( NewsNation) — National Institutes of Health director Jay Bhattacharya believes mRNA vaccine technology is “promising” but ...

Canceling federal mRNA vaccine projects threatens much more than pandemic response, according to Michigan State University’s ...

Scripps News speaks with vaccine experts who say HHS funding cuts targeting mRNA vaccines could hinder other vaccine research ...

The Trump administration’s decision to halt nearly $500 million for mRNA vaccine research has made investors more hesitant to ...

US Government cuts to mRNA vaccine research could set technological advances, reduce access to therapies, and raise their costs.

Read more on where he believes the middle ground might be. Investors are more wary than ever of mRNA vaccines Despite an ...

Enphase Energy (ENPH) retained its spot as the most shorted S&P 500 (SP500) stock as a percentage of float in July, followed ...